An FDA advisory committee voted unanimously in favour of a booster dose of Johnson & Johnson's one-shot COVID-19 vaccine on Friday, as panellists suggested it should have been used as a two-dose ...
Johnson & Johnson's COVID-19 vaccine has been a minor player in the US vaccination drive so far, but the company hopes it can have a bigger role as a booster shot. The drugmaker has filed for ...
A booster dose of Johnson & Johnson Inc's single-dose COVID-19 vaccine was 84% effective at preventing hospitalization in South African healthcare workers who became infected as the Omicron ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback